Louise Farley expands on Deepbridge Capital’s position as a ‘business builder’, underscored by its management team’s background, and how that translates into its investment strategy. Also touched on are demystifying ‘life sciences’ for advisers and their clients, and increased interest in investee businesses as the public focus shifts from tax reliefs to growth and innovation. She talks about increasing diversity in the industry –  from business angels to company founders – and a collaborative effort to back British business.